← Back to Search

Procedure

Laser Surgery for Vasa Previa (FLUMEN Trial)

N/A
Waitlist Available
Led By Alireza Shamshirsaz
Research Sponsored by Boston Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up when the last (20th) participant undergoes flp surgery, about 3 years from study start date.
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study the safety and effectiveness of a fetal surgery called fetoscopic laser photocoagulation (FLP) for the treatment of vasa previa (VP), a dangerous pregnancy complication

Who is the study for?
This trial is for pregnant individuals diagnosed with vasa previa, a condition where fetal blood vessels cover the womb's entrance. Participants should be in their third trimester and have not undergone any prior treatment for vasa previa. Specific inclusion and exclusion criteria details are not provided.
What is being tested?
The study tests fetoscopic laser photocoagulation (FLP), a minimally invasive surgery aiming to correct abnormal fetal blood vessels in pregnancies complicated by vasa previa. The goal is to reduce severe bleeding risks, potentially avoid long hospital stays before delivery, and enable vaginal birth.
What are the potential side effects?
Potential side effects of FLP may include complications from surgery such as bleeding or infection, adverse reactions affecting the mother or fetus due to the procedure itself, but exact side effects are not detailed in this summary.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~when the last (20th) participant undergoes flp surgery, about 3 years from study start date.
This trial's timeline: 3 weeks for screening, Varies for treatment, and when the last (20th) participant undergoes flp surgery, about 3 years from study start date. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Gestational age at delivery
Mode of delivery
Placental function
+4 more
Secondary study objectives
Cause for hospital admission
Duration of hospital stay
Fetal brain structure
+14 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Fetoscopic Laser Photocoagulation SurgeryExperimental Treatment1 Intervention
Pregnant individuals diagnosed with type II vasa previa will undergo fetoscopic laser photocoagulation.

Find a Location

Who is running the clinical trial?

Boston Children's HospitalLead Sponsor
786 Previous Clinical Trials
5,582,321 Total Patients Enrolled
1 Trials studying Vasa Previa
50 Patients Enrolled for Vasa Previa
Alireza ShamshirsazPrincipal InvestigatorDirector, Maternal Fetal Care Center
Alireza Shamshirsaz, MDPrincipal InvestigatorDirector, Maternal Fetal Care Center; Chief, Division of Fetal Medicine and Surgery
1 Previous Clinical Trials
10 Total Patients Enrolled
~13 spots leftby Aug 2027